脂质体包裹重组NE蛋白戊肝疫苗候选物免疫小鼠的特定记忆B细胞应答及CD4+中枢与效应记忆T细胞参与
本研究在Balb/c小鼠中评估脂质体包裹重组NE蛋白戊肝疫苗候选物(5μg或1μg,2剂,间隔4周)免疫后至420天的抗体持久性、记忆B细胞与记忆T细胞应答。5μg组诱导的anti-HEV IgG估计可终身持续,加强后高抗体滴度组100%检出HEV特异性抗体分泌浆细胞,且仅高滴度组CD4+中枢与效应记忆T细胞频率升高。
要点
- 5μg候选疫苗诱导的anti-HEV IgG应答估计可终身持续。
- 加强后第6天,高滴度组100%、低滴度组50%小鼠检出HEV特异性抗体分泌浆细胞。
- 仅高anti-HEV IgG滴度组小鼠CD4+中枢与效应记忆T细胞频率高。
核心结论
- 该疫苗候选物有效产生持久和回忆性抗体应答,引发CD4+记忆T细胞参与,并触发记忆B细胞在加强后分化为抗体分泌浆细胞。
研究设计与样本
- 在Balb/c小鼠中评估脂质体包裹重组NE蛋白戊肝疫苗候选物(5μg,2剂,间隔4周)免疫后至420天的抗体与细胞应答。
- 1μg剂量组小鼠仅评估加强剂量后的回忆应答。
主要发现
- 5μg剂量免疫小鼠诱导强anti-HEV IgG应答,估计可终身持续。
- 免疫后第120天,免疫小鼠记忆B细胞频率高于仅接受佐剂的小鼠。
- 1μg剂量免疫小鼠anti-HEV IgG滴度较低。
- 加强剂量在高(>800GMT,5μg)和低(≤100GMT,1μg)anti-HEV IgG滴度小鼠中均产生增强的抗体应答。
- 加强后第6天,高和低anti-HEV IgG滴度小鼠中分别有100%和50%检出HEV特异性抗体分泌浆细胞,而CD4+中枢与效应记忆T细胞频率仅在高anti-HEV IgG滴度小鼠中高。
临床怎么用
- 作者认为该评估疫苗候选物免疫原性的方法可用于未来人用HEV疫苗试验中探索HEV特异性记忆应答的持久性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Liposome encapsulated neutralizing epitope protein of Hepatitis E virus (HEV), rNEp, our Hepatitis E vaccine candidate, was shown to be immunogenic and safe in pregnant and non-pregnant mice and yielded sterilizing immunity in rhesus monkeys. METHODS: The current study in Balb/c mice assessed the levels and persistence of anti-HEV IgG antibodies by ELISA, frequencies of B, memory B, T and memory T cells by flow cytometry and HEV-specific IgG secreting memory B cells by ELISPOT till 420days post immunization (PI) with 5?g rNEp encapsulated in liposome based adjuvant (2 doses, 4weeks apart). Mice immunized with a lower dose (1?g) were assessed only for anamnestic response post booster dose. RESULTS: Vaccine candidate immunized mice (5?g dose) elicited strong anti-HEV IgG response that was estimated to persist for lifetime. At day 120 PI, frequency of memory B cells was higher in immunized mice than those receiving adjuvant alone. Anti-HEV IgG titers were lower in mice immunized with 1?g dose. A booster dose yielded a heightened antibody response in mice with both high (>800GMT, 5?g) and low (?100GMT, 1?g) anti-HEV IgG titers. At day 6th post booster dose, HEV-specific antibody secreting plasma cells (ASCs) were detected in 100% and 50% of mice with high and low anti-HEV IgG titers, respectively, whereas the frequencies of CD4+ central and effector memory T cells were high in mice with high anti-HEV IgG titers only. CONCLUSIONS: Taken together, the vaccine candidate effectively generates persistent and anamnestic antibody response, elicits participation of CD4+ memory T cells and triggers memory B cells to differentiate into ASCs upon boosting. This approach of assessing the immunogenicity of vaccine candidate could be useful to explore the longevity of HEV-specific memory response in future HEV vaccine trials in human.
引用
- Kulkarni SP, Thanapati S, Arankalle VA, et al. Specific memory B cell response and participation of CD4+ central and effector memory T cells in mice immunized with liposome encapsulated recombinant NE protein based Hepatitis E vaccine candidate. Vaccine. 2016. PMID: 27997340. doi:10.1016/j.vaccine.2016.10.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。